Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
ASTRAZENECA PHARMA INDIA LTD.
AstraZeneca Pharma India Ltd.
NSE: ASTRAZEN | BSE: 506820
Expensive Underperformer
Download real time
8086.00
-142.50
(
-1.73
%)
6,468
NSE+BSE Volume
NSE
16 Jul, 2026 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
CDSCO Approval
AstraZeneca Pharma gets CDSCO nod for Benralizumab sol, with a market size of up to $2 bn in 2025
See details
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
AstraZeneca Pharma - ASTRAZEN, 506820 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for AstraZeneca Pharma
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
AstraZeneca Pharma Bonus history
AstraZeneca Pharma has not announced any bonus since Jan 1, 2000.
See all forthcoming Bonus and Splits
Split history for AstraZeneca Pharma
AstraZeneca Pharma has split the face value 1 time since June 15, 2006. AstraZeneca Pharma had last split the face value of its shares from ₹10 to ₹2 in 2006.The share has been quoting on an ex-split basis from June 15, 2006.
Ex-Date
Old FV
New FV
Record Date
15 Jun 2006
10
2
22 Jun 2006
See all forthcoming Bonus and split
Dividend history for AstraZeneca Pharma
AstraZeneca Pharma has declared 17 dividends since April 17, 2003.
In the past 12 months, AstraZeneca Pharma has declared an equity dividend amounting to ₹32.00 per share.
At the current share price of ₹8086.0000, AstraZeneca Pharma's dividend yield is 0.40%.
Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
18 Jul 2025
32.000
FINAL
18 Jul 2025
Equity Share
05 Jul 2024
24.000
FINAL
05 Jul 2024
Equity Share
14 Jul 2023
16.000
FINAL
14 Jul 2023
Equity Share
07 Jul 2022
8.000
FINAL
08 Jul 2022
Equity Share
18 Aug 2021
2.000
INTERIM
20 Aug 2021
Equity Share
20 Aug 2020
2.000
INTERIM
21 Aug 2020
Equity Share
20 Aug 2019
1.000
INTERIM
21 Aug 2019
Equity Share
09 Jul 2012
3.500
FINAL
-
Equity Share
07 Jul 2011
10.000
FINAL
-
Equity Share
06 May 2010
10.000
FINAL
-
Equity Share
29 Apr 2009
15.000
FINAL
-
Equity Share
11 Apr 2008
15.000
FINAL
-
Equity Share
22 Mar 2007
12.000
INTERIM
24 Mar 2007
Equity Share
12 Apr 2006
20.000
FINAL
-
Equity Share
18 Mar 2005
50.000
FINAL
-
Equity Share
16 Apr 2004
3.900
FINAL
-
Equity Share
17 Apr 2003
3.700
FINAL
-
Equity Share
VIEW MORE
See all forthcoming dividends
Check out stocks with top dividend.
Board Meetings - AstraZeneca Pharma
The latest board meeting for AstraZeneca Pharma took place on 26 May 2026, for the purpose of Audited Results & Final Dividend
Ex-Date
Purpose
Notes
26 May 2026
Audited Results & Final Dividend
-
11 Feb 2026
Quarterly Results
-
07 Nov 2025
Quarterly Results
-
14 Aug 2025
Quarterly Results
-
30 May 2025
Audited Results & Dividend
-
11 Feb 2025
Quarterly Results
-
13 Nov 2024
Quarterly Results
-
08 Aug 2024
Quarterly Results
-
27 May 2024
Audited Results & Dividend
-
08 Feb 2024
Quarterly Results
-
See all Board Meetings for AstraZeneca Pharma
AstraZeneca Pharma Rights history
AstraZeneca Pharma has not issued
any
rights since Jan 1, 2000.
See all Rights History for AstraZeneca Pharma